Skip to main content

Spectrum: Autism Research News

Tag: signaling imbalance

January 2015

Surplus of neurons spurs autism traits in mice

by  /  15 January 2015

Fetal mice that have too many neurons grow to show social deficits and repetitive behaviors. The finding, reported 11 December in Cell Reports, debuts a mouse model of autism that’s based on a biological abnormality seen in some people with the disorder.

Comments
November 2014

Different autism subtypes share same genetic signature

by  /  20 November 2014

A rare form of autism linked to a duplication of the 15q11-13 chromosomal region shares a molecular signature with more common forms of the disorder, suggests unpublished research presented yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

Comments

Autism-linked gene guides growth of subtype of neurons

by  /  19 November 2014

Mice missing PTEN, a strong autism candidate gene, in a subtype of inhibitory neurons in one part of the brain show signaling abnormalities and social deficits. Researchers presented the unpublished work yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

Comments

Sensors shed light on levels of chemical messengers in mice

by  /  12 November 2014

Cells modified to carry fluorescent sensors can help researchers detect the levels of various chemical messengers in the brains of living mice.

Comments
July 2014

Autism gene affects brain function early in development

by  /  28 July 2014

Mutations in a gene linked to intellectual disability and sometimes autism may lead to a permanent boost in brain activity, according to a study published 18 June in Neuron.

Comments
June 2014

How to evaluate new medications for autism

by  /  10 June 2014

There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.

Comments
April 2014

Low-dose sedative eases autism symptoms in mice

by  /  3 April 2014

The equivalent of one-tenth of a single pill of the anxiety drug clonazepam alleviates many autism-like behaviors in a mouse model of the disorder, according to a study published 19 March in Neuron.

Comments
February 2014

How to evaluate the ‘intense world’ paradigm?

by  /  11 February 2014

What evidence supports the idea that autism stems from overactive brain responses to sensory input? Researchers weigh in on this controversial theory.

Comments

Drug calms overly excitable brains in autism rodent models

by  /  10 February 2014

The blood pressure drug bumetanide normalizes a deficit in brain activity in two rodent models of autism, according to a study published last week in Science. The study hints at a mechanism underlying the drug’s benefits for people with autism.

Comments
January 2014

Intense world theory raises intense worries

by ,  /  21 January 2014

The ‘intense world theory’ of autism, which has attracted much interest from the popular press, has received very little academic scrutiny. Uta Frith and Anna Remington ask: Is it as positive as it purports to be, and what does it mean for autism?

Comments